Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. - Wikidata - awgldk - TriplyDB

Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.

Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.

http://www.wikidata.org/entity/Q40485168

about

Therapeutic potential of RNA interference against cancer Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect.Advances in Systemic siRNA Delivery Inhibition of lung tumor growth in nude mice by siRNA(CD31) targeting PECAM-1.Self-assembled lipid nanomedicines for siRNA tumor targeting.Non-viral nanocarriers for siRNA delivery in breast cancer.Efficient and targeted delivery of siRNA in vivo.Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin Novel cholesterol-based cationic lipids as transfecting agents of DNA for efficient gene delivery.B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastoma.Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer RNA interference for treating haematological malignancies.Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.Cancer gene therapy targeting angiogenesis: an updated review.Neutral polymeric micelles for RNA delivery Nonviral delivery of synthetic siRNAs in vivo.Concepts in in vivo siRNA delivery for cancer therapy.Nonviral methods for siRNA delivery Use of liposomes as drug delivery vehicles for treatment of melanoma.Lipid-based systemic delivery of siRNA.RNA interference as an anticancer therapy: a patent perspective.Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C.Atelocollagen-mediated drug discovery technology.siRNA: novel therapeutics from functional genomics.Therapeutic potential of siRNA and DNAzymes in cancer.α-Tocopherol derived lipid dimers as efficient gene transfection agents. Mechanistic insights into lipoplex internalization and therapeutic induction of apoptotic activity.Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.Chemically modified short interfering hybrids (siHYBRIDS): nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2.A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium.RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.Transfection by cationic gemini lipids and surfactants

P2860

Q28253746-E25688D0-09C6-48D6-A30E-F3BEFEBAC271 Q33265007-E425E973-6DD0-4AB4-A40D-3AAB91AF282E Q33613316-54B0B854-3752-4103-A8CE-06353EE3DCE0 Q33778468-E7298070-70B9-4B15-924C-D7BA6C8AF89C Q33907953-285C946E-3845-4FAD-8D2B-9682C09E6166 Q34079608-233C36C9-8EA5-4D05-8814-A50E66191A45 Q34149828-1CA372FF-54DE-4319-BC14-C439754CA99B Q35298265-32B88954-D92C-44BF-8E92-DBCAD89DBAC0 Q35381275-38C01ED9-D8F7-4F69-85AF-102BF75AF18A Q35444346-C9D796F7-35EF-4502-8C24-29FFE30501AC Q35982462-FF7E80C5-718F-4B6A-A581-6A7FC3E34CD0 Q36327055-E4E199CC-9049-426B-BA86-ABE6981F61EF Q36631534-B3FE0B9C-B382-430E-9828-B6640582B1E6 Q36655133-8EDDD315-6293-4665-832B-E9466AF0C4B2 Q36763827-DC19E891-8AA7-4C2F-8DF1-F5180F910DE7 Q37024768-894837DA-1567-485C-9EA4-C9FE1CE95710 Q37217876-C2DEBCC9-E98F-431D-9F84-D01DF679CFD9 Q37360226-2ACCE585-7C81-4A3E-958D-3BE8D898138F Q37406217-FE89AFB4-1EFD-4E1E-BAE6-768E061ED51E Q37425606-E1D561D3-FBB3-4107-B906-97D4C3A8E430 Q37481329-409DAC4F-B118-47F2-BD23-BBE9343515F3 Q38050165-28065B4F-E3C4-4A54-B351-6E62DC367A33 Q38089845-03FDD9E1-F4DE-4FE3-A741-C30AE6A36F4D Q38229425-A8722838-AD6B-4804-B9FA-794ECDA59ADA Q38242397-FC0D60F8-B304-42BA-A5A7-3676517D36FF Q38922635-9D0EAF11-D92C-42C9-86C6-39EF85CDA122 Q39703963-5F1284D2-9AB0-4BEC-AB95-06E795739D4D Q40244901-223F823A-5E09-4C3B-9CA6-61992004B838 Q40290076-871983D8-A0DB-4868-93F6-7AD81F356EBB Q40290084-BDDB8EDB-F6D2-4A82-B040-6DF2C04F8E64 Q40355127-E04D3D63-AA18-4C00-AC57-162DE34091F9 Q48256868-D0E0FEEE-E24E-4E61-879B-96B8A4D6FF1E Q57139324-B4324C1A-4EBD-4CE0-8BC3-A01F004D640A

P2860

Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.

http://www.wikidata.org/entity/Q40485168

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Novel cationic cardiolipin ana ...... delivery in vitro and in vivo.

@en

type

label

Novel cationic cardiolipin ana ...... delivery in vitro and in vivo.

@en

prefLabel

Novel cationic cardiolipin ana ...... delivery in vitro and in vivo.

@en

P1433

Q40485168-D9B0F42E-03D7-4FAC-9E14-BBFF93C47014

P1476

Q40485168-55DB71B9-A05E-4C7E-AA58-B4BC12F71AA2

P2093

Q40485168-0C099F8C-D8CC-4BE0-9227-3494B7F5EDE0

Q40485168-58DB84E4-C73B-4BAC-A793-8C6AB07C55DF

Q40485168-69C8C6CB-9911-4E16-8C47-95A58E997DC4

Q40485168-8661A633-5981-4C55-B059-92ED0C2249BC

Q40485168-98BEE36E-A604-4657-9A0E-CA5C43486002

Q40485168-9DEA683E-FA2C-4EBC-AB22-6E48330A5F47

Q40485168-A1620A60-2850-4CBE-8614-C4FED8AB7ABE

Q40485168-C93EB9D7-62F6-4336-9A58-5770911F8CF8

Q40485168-D6F797FE-EAD3-412D-8EA0-56730A3EFBCC

P2860

Q40485168-03684D8A-8314-4529-8A3F-251A334D65BC

Q40485168-07F146E0-16E9-47BC-B254-8BFF8DB615BA

Q40485168-15594442-5815-4644-AD79-9157789E6F5D

Q40485168-195D0A1D-028C-409E-8DAD-5CE47ADB2CE2

Q40485168-36F74C2A-D37D-431B-B39A-D17122937E7E

Q40485168-4070A131-AA8D-4537-9613-0F22B0D6A4C7

Q40485168-497E3300-08A6-46DC-BA08-A04A673E2ED1

Q40485168-499DA77F-8A73-4D8F-930A-7F711E91FC2C

Q40485168-5820F65D-2F68-4FC8-A332-60F60245254D

Q40485168-58E3CE13-E2E8-4371-863E-362F3963A3F3

P2888

Q40485168-49EACAE5-FE54-4E20-B499-211CF507AA09

P304

Q40485168-6C47E048-94C9-4FE3-A427-3010859BF17A

P31

Q40485168-5F7B551E-7207-4EE6-92CC-8522C5E60145

P356

Q40485168-CCBFBB8A-D7AE-4DBF-85A1-73F76D0A6E18

P433

Q40485168-63A932B1-5FBE-406A-BAAD-35F4DB09E12B

P478

Q40485168-4D35B3DB-4395-4CCB-AEC5-7B547B1CEEDF

P577

Q40485168-1DD3CCDE-431F-4017-83C4-3E2018DB25E4

P5875

Q40485168-751061C6-EE09-4D97-958C-EE02BAB0671B

P6179

Q40485168-9CC2B629-4EBC-4244-932F-04D83A4458C7

P698

Q40485168-718E1B25-16C1-41A4-A4B3-046B377C379A

P356

P1433

Cancer Gene Therapy

P1476

Novel cationic cardiolipin ana ...... delivery in vitro and in vivo.

@en

P2093

Bruce Miller

http://www.w3.org/2001/XMLSchema#string

Danielle Carbonaro

http://www.w3.org/2001/XMLSchema#string

Imran Ahmad

http://www.w3.org/2001/XMLSchema#string

Jinkang Wang

http://www.w3.org/2001/XMLSchema#string

Moghis U Ahmad

http://www.w3.org/2001/XMLSchema#string

Pei-Yu Chien

http://www.w3.org/2001/XMLSchema#string

Sabrina Lei

http://www.w3.org/2001/XMLSchema#string

Saifuddin Sheikh

http://www.w3.org/2001/XMLSchema#string

Shoukath M Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

New colorimetric cytotoxicity assay for anticancer-drug screening

Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice.

In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.

Cationic liposomes for gene delivery: from biophysics to biological applications.

Short interfering RNA (siRNA)-mediated RNA interference (RNAi) in human cells.

Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo

Formation of stable cationic lipid/DNA complexes for gene transfer.

Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery.

P2888

P304

321-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CGT.7700793

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8149768

http://www.w3.org/2001/XMLSchema#string

P6179

1046939001

http://www.w3.org/2001/XMLSchema#string

P698

15578064

http://www.w3.org/2001/XMLSchema#string